Get started
Live feed
·
INSIDERFilingvia Quantisnow
Inhibikase Therapeutics Inc. logo

SEC Form 4 filed by Inhibikase Therapeutics Inc.

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.
Quantisnow market dataNASDAQ
Inhibikase Therapeutics Inc. logo
IKT
Inhibikase Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2020
Get push alerts for IKT

Follow IKT and get a push notification the moment its next story breaks.

Full IKT profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IKT (Inhibikase Therapeutics Inc.) and more on Quantisnow.